Displaying 41 - 57 of 57
Omnicare, Inc., a corporation, In the Matter of
The Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and others. In its complaint, the FTC charges that a deal combining Omnicare and PharMerica would significantly increase Omnicare's already substantial bargaining leverage by dramatically increasing the number of skilled nursing facilities, known as SNFs, that receive long-term care pharmacy services from the company. Due to its substantial market share, the FTC alleges that the combined firm likely would be a "must have" for Medicare Part D prescription drug plans, which are responsible for providing subsidized prescription drug benefit coverage for most SNF residents and other Medicare beneficiaries. On 2/23/2012, the FTC dismissed the complaint in light of Omnicare's decision to abandon the proposed transaction.
Rite Aid Corporation and The Jean Coutu Group (PJC), Inc., In the Matter of
FTC Challenges Rite Aid's Proposed $3.5 Billion Acquisition of Brooks and Eckerd Pharmacies from Canadas Jean Coutu Group, Inc.
Asociacion de Farmacias Region de Arecibo, Inc., and Ricardo L.Alvarez Class, individually and as an officer of Associacion de Farmacias Region de Arecibo, Inc.
A pharmacy association in northern Puerto Rico and Ricardo Alvarez Class settled charges that they engaged in an illegal boycott in an attempt to obtain higher reimbursement rates for pharmacy goods and services under the government's managed care plan for the indigent. The consent order prohibits the members of the association and Mr. Class from engaging in joint negotiations for prices and from threatening to boycott or refusing to provide pharmacy services.
Institutional Pharmacy Network, Evergreen Pharmaceutical, Inc., et al., In the Matter of
A final order prohibits five institutional pharmacies from engaging in any joint price negotiation or price agreements for the provision of prescription drugs in an attempt to maximize reimbursement rates with managed care organizations.
CVS To Pay $600,000 Civil Penalty for Violating FTC Asset Maintenance Agreement
RiteAid To Pay $900,000 in Civil Penalties for Failure To Divest Three Drug Stores in Maine and New Hampshire as Required under FTC Agreement
CVS To Divest 120 Revco Drug Stores in VA, NY To Settle FTC Charges...
J.C. Penney Company, Inc., and Thrift Drug, Inc., In the Matter of
Separate final consent orders settle charges that the acquisitions of Eckerd Corporation and 190 Rite Aid stores in North and South Carolina would give J.C. Penney a dominant position in four metropolitan areas and increase its ability to raise prices for the sale of pharmacy services to third party payers. The orders require the divestitures of 34 Thrifty drug stores and 127 Rite Aid drug stores.
Listening Session: Anticompetitive Conduct by Pharmaceutical Companies Impeding Generic or Biosimilar Competition
Listening Session: Turning Insights into Action to Reduce Drug Prices
Listening Session: Formulary and Benefit Practices and Regulatory Abuse Impacting Drug Competition
Open Commission Meeting - July 20, 2023
Open Commission Meeting - February 17, 2022
Monitors: Expert eyes and ears in Commission orders
Displaying 41 - 57 of 57